1
|
Gao ZG, Haddad M, Jacobson KA. A 2B adenosine receptor signaling and regulation. Purinergic Signal 2024:10.1007/s11302-024-10025-y. [PMID: 38833181 DOI: 10.1007/s11302-024-10025-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 05/20/2024] [Indexed: 06/06/2024] Open
Abstract
The A2B adenosine receptor (A2BR) is one of the four adenosine-activated G protein-coupled receptors. In addition to adenosine, protein kinase C (PKC) was recently found to activate the A2BR. The A2BR is coupled to both Gs and Gi, as well as Gq proteins in some cell types. Many primary cells and cell lines, such as bladder and breast cancer, bronchial smooth muscle, skeletal muscle, and fat cells, express the A2BR endogenously at high levels, suggesting its potentially important role in asthma, cancer, diabetes, and other conditions. The A2BR has been characterized as both pro- and anti-inflammatory, inducing cell type-dependent secretion of IL-6, IL-8, and IL-10. Theophylline and enprofylline have long been used for asthma treatment, although it is still not entirely clear if their A2BR antagonism contributes to their therapeutic effects or side effects. The A2BR is required in ischemic cardiac preconditioning by adenosine. Both A2BR and protein kinase C (PKC) contribute to cardioprotection, and both modes of A2BR signaling can be blocked by A2BR antagonists. Inhibitors of PKC and A2BR are in clinical cancer trials. Sulforaphane and other isothiocyanates from cruciferous vegetables such as broccoli and cauliflower have been reported to inhibit A2BR signaling via reaction with an intracellular A2BR cysteine residue (C210). A full, A2BR-selective agonist, critical to elucidate many controversial roles of the A2BR, is still not available, although agonist-bound A2BR structures have recently been reported.
Collapse
Affiliation(s)
- Zhan-Guo Gao
- Molecular Recognition Section, Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
| | - Mansour Haddad
- Faculty of Pharmacy, Yarmouk University, Irbid, 21163, Jordan
| | - Kenneth A Jacobson
- Molecular Recognition Section, Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
| |
Collapse
|
2
|
Caiazzo E, Cerqua I, Turiello R, Riemma MA, De Palma G, Ialenti A, Roviezzo F, Morello S, Cicala C. Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge. Biomolecules 2022; 12:biom12050697. [PMID: 35625624 PMCID: PMC9139122 DOI: 10.3390/biom12050697] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 05/03/2022] [Accepted: 05/11/2022] [Indexed: 02/04/2023] Open
Abstract
Ecto-5′-nucleotidase (CD73), the ectoenzyme that together with CD39 is responsible for extracellular ATP hydrolysis and adenosine accumulation, regulates immune/inflammatory processes by controlling innate and acquired immunity cell functions. We previously demonstrated that CD73 is required for the assessment of a controlled allergic sensitization, in mice. Here, we evaluated the response to aerosolized allergen of female-sensitized mice lacking CD73 in comparison with their wild type counterpart. Results obtained show, in mice lacking CD73, the absence of airway hyperreactivity in response to an allergen challenge, paralleled by reduced airway CD23+B cells and IL4+T cells pulmonary accumulation together with reduced mast cells accumulation and degranulation. Our findings indicate CD73 as a potential therapeutic target for allergic asthma.
Collapse
Affiliation(s)
- Elisabetta Caiazzo
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
| | - Ida Cerqua
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
| | - Roberta Turiello
- Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy; (R.T.); (S.M.)
- PhD Program in Drug Discovery and Development, University of Salerno, 84084 Fisciano, Italy
| | - Maria Antonietta Riemma
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
| | - Giacomo De Palma
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
| | - Armando Ialenti
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
| | - Fiorentina Roviezzo
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
| | - Silvana Morello
- Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy; (R.T.); (S.M.)
| | - Carla Cicala
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy; (E.C.); (I.C.); (M.A.R.); (G.D.P.); (A.I.); (F.R.)
- Correspondence:
| |
Collapse
|
3
|
Caiazzo E, Cerqua I, Riemma MA, Turiello R, Ialenti A, Schrader J, Fiume G, Caiazza C, Roviezzo F, Morello S, Cicala C. Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5'-Nucleotidase (CD73). Front Pharmacol 2020; 11:589343. [PMID: 33328996 PMCID: PMC7734328 DOI: 10.3389/fphar.2020.589343] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2020] [Accepted: 10/20/2020] [Indexed: 12/15/2022] Open
Abstract
The airways are a target tissue of type I allergies and atopy is the main etiological factor of bronchial asthma. A predisposition to allergy and individual response to allergens are dependent upon environmental and host factors. Early studies performed to clarify the role of extracellular adenosine in the airways highlighted the importance of adenosine-generating enzymes CD73, together with CD39, as an innate protection system against lung injury. In experimental animals, deletion of CD73 has been associated with immune and autoimmune diseases. Our experiments have been performed to investigate the role of CD73 in the assessment of allergic airway inflammation following sensitization. We found that in CD73−/− mice sensitization, induced by subcutaneous ovalbumin (OVA) administration, increased signs of airway inflammation and atopy developed, characterized by high IgE plasma levels and increased pulmonary cytokines, reduced frequency of lung CD4+CD25+Foxp3+ T cells, but without bronchial hyperreactivity, compared to sensitized wild type mice. Our results provide evidence that the lack of CD73 causes an uncontrolled allergic sensitization, suggesting that CD73 is a key molecule at the interface between innate and adaptive immune response. The knowledge of host immune factors controlling allergic sensitization is of crucial importance and might help to find preventive interventions that could act before an allergy develops.
Collapse
Affiliation(s)
- Elisabetta Caiazzo
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Ida Cerqua
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Maria Antonietta Riemma
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Roberta Turiello
- Department of Pharmacy, University of Salerno, Salerno, Italy.,PhD Program in Drug Discovery and Development, University of Salerno, Salerno, Italy
| | - Armando Ialenti
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Jurgen Schrader
- Department of Molecular Cardiology, Heinrich Heine University, Düsseldorf, Germany
| | - Giuseppe Fiume
- Department of Experimental and Clinical Medicine, University of Catanzaro Magna Graecia, Catanzaro, Italy
| | - Carmen Caiazza
- Department of Molecular Medicine and Medical Biotechnologies, School of Medicine and Surgery, University of Naples 'Federico II', Naples, Italy
| | - Fiorentina Roviezzo
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - Silvana Morello
- Department of Pharmacy, University of Salerno, Salerno, Italy
| | - Carla Cicala
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
| |
Collapse
|
4
|
Lee MK, Lim KH, Millns P, Mohankumar SK, Ng ST, Tan CS, Then SM, Mbaki Y, Ting KN. Bronchodilator effects of Lignosus rhinocerotis extract on rat isolated airways is linked to the blockage of calcium entry. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2018; 42:172-179. [PMID: 29655683 DOI: 10.1016/j.phymed.2018.03.025] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/16/2017] [Revised: 02/02/2018] [Accepted: 03/12/2018] [Indexed: 06/08/2023]
Abstract
BACKGROUND Lignosus rhinocerotis (Cooke) Ryvarden is a popular medicinal mushroom used for centuries in Southeast Asia to treat asthma and chronic cough. The present study aimed to investigate the effect of this mushroom on airways patency. MATERIALS AND METHODS The composition of L. rhinocerotis TM02 cultivar was analyzed. Organ bath experiment was employed to study the bronchodilator effect of Lignosus rhinocerotis cold water extract (CWE) on rat isolated airways. Trachea and bronchus were removed from male Sprague-Dawley rats, cut into rings of 2 mm, pre-contracted with carbachol before adding CWE into the bath in increasing concentrations. To investigate the influence of incubation time, tissues were exposed to intervals of 5, 15 and 30 min between CWE concentrations after pre-contraction with carbachol in subsequent protocol. Next, tissues were pre-incubated with CWE before the addition of different contractile agents, carbachol and 5-hydroxytrptamine (5-HT). The bronchodilator effect of CWE was compared with salmeterol and ipratropium. In order to uncover the mechanism of action of CWE, the role of beta-adrenoceptor, potassium and calcium channels was investigated. RESULTS Composition analysis of TM02 cultivar revealed the presence of β-glucans and derivatives of adenosine. The extract fully relaxed the trachea at 3.75 mg/ml (p < 0.0001) and bronchus at 2.5 mg/ml (p < 0.0001). It was observed that lower concentrations of CWE were able to fully relax both trachea and bronchus but at a longer incubation interval between concentrations. CWE pre-incubation significantly reduced the maximum responses of carbachol-induced contractions (in both trachea, p = 0.0012 and bronchus, p = 0.001), and 5-HT-induced contractions (in trachea, p = 0.0048 and bronchus, p = 0.0014). Ipratropium has demonstrated a significant relaxation effect in both trachea (p = 0.0004) and bronchus (p = 0.0031), whereas salmeterol has only affected the bronchus (p = 0.0104). The involvement of β2-adrenoceptor and potassium channel in CWE-mediated airway relaxation is ruled out, but the bronchodilator effect was unequivocally affected by influx of calcium. CONCLUSIONS The bronchodilator effect of L. rhinocerotis on airways is mediated by calcium signalling pathway downstream of Gαq-coupled protein receptors. The airway relaxation effect is both concentration- and incubation time-dependent. Our findings provide unequivocal evidence to support its traditional use to relieve asthma and cough.
Collapse
Affiliation(s)
- Mei-Kee Lee
- Department of Biomedical Sciences, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia
| | - Kuan-Hon Lim
- School of Pharmacy, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia
| | - Paul Millns
- School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK
| | - Suresh Kumar Mohankumar
- JSS College of Pharmacy, Rocklands, Ootacamund-643001, Tamil Nadu, India; a constituent college of JSS Academy of Higher Education & Research, Mysuru, Karnataka, India
| | - Szu-Ting Ng
- LiGNO Biotech Sdn Bhd, Balakong Jaya 43300, Malaysia
| | - Chon-Seng Tan
- LiGNO Biotech Sdn Bhd, Balakong Jaya 43300, Malaysia
| | - Sue-Mian Then
- Department of Biomedical Sciences, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia
| | - Yvonne Mbaki
- School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK
| | - Kang-Nee Ting
- Department of Biomedical Sciences, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia.
| |
Collapse
|
5
|
Gao ZG, Jacobson KA. Purinergic Signaling in Mast Cell Degranulation and Asthma. Front Pharmacol 2017; 8:947. [PMID: 29311944 PMCID: PMC5744008 DOI: 10.3389/fphar.2017.00947] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Accepted: 12/14/2017] [Indexed: 11/13/2022] Open
Abstract
Mast cells are responsible for the majority of allergic conditions. It was originally thought that almost all allergic events were mediated directly only via the high-affinity immunoglobulin E receptors. However, recent evidence showed that many other receptors, such as G protein-coupled receptors and ligand-gated ion channels, are also directly involved in mast cell degranulation, the release of inflammatory mediators such as histamine, serine proteases, leukotrienes, heparin, and serotonin. These mediators are responsible for the symptoms in allergic conditions such as allergic asthma. In recent years, it has been realized that purinergic signaling, induced via the activation of G protein-coupled adenosine receptors and P2Y nucleotide receptors, as well as by ATP-gated P2X receptors, plays a significant role in mast cell degranulation. Both adenosine and ATP can induce degranulation and bronchoconstriction on their own and synergistically with allergens. All three classes of receptors, adenosine, P2X and P2Y are involved in tracheal mucus secretion. This review will summarize the currently available knowledge on the role of purinergic signaling in mast cell degranulation and its most relevant disease, asthma.
Collapse
Affiliation(s)
- Zhan-Guo Gao
- Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States
| | - Kenneth A Jacobson
- Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States
| |
Collapse
|
6
|
Wimmer M, Alessandrini F, Gilles S, Frank U, Oeder S, Hauser M, Ring J, Ferreira F, Ernst D, Winkler JB, Schmitt-Kopplin P, Ohnmacht C, Behrendt H, Schmidt-Weber C, Traidl-Hoffmann C, Gutermuth J. Pollen-derived adenosine is a necessary cofactor for ragweed allergy. Allergy 2015; 70:944-54. [PMID: 25939785 DOI: 10.1111/all.12642] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/28/2015] [Indexed: 01/22/2023]
Abstract
BACKGROUND Ragweed (Ambrosia artemisiifolia) is a strong elicitor of allergic airway inflammation with worldwide increasing prevalence. Various components of ragweed pollen are thought to play a role in the development of allergic responses. The aim of this study was to identify critical factors for allergenicity of ragweed pollen in a physiological model of allergic airway inflammation. METHODS Aqueous ragweed pollen extract, the low molecular weight fraction or the major allergen Amb a 1 was instilled intranasally on 1-11 consecutive days, and allergic airway inflammation was evaluated by bronchoalveolar lavage, lung histology, serology, gene expression in lung tissue, and measurement of lung function. Pollen-derived adenosine was removed from the extract enzymatically to analyze its role in ragweed-induced allergy. Migration of human neutrophils and eosinophils toward supernatants of ragweed-stimulated bronchial epithelial cells was analyzed. RESULTS Instillation of ragweed pollen extract, but not of the major allergen or the low molecular weight fraction, induced specific IgG1 , pulmonary infiltration with inflammatory cells, a Th2-associated cytokine signature in pulmonary tissue, and impaired lung function. Adenosine aggravated ragweed-induced allergic lung inflammation. In vitro, human neutrophils and eosinophils migrated toward supernatants of bronchial epithelial cells stimulated with ragweed extract only if adenosine was present. CONCLUSIONS Pollen-derived adenosine is a critical factor in ragweed-pollen-induced allergic airway inflammation. Future studies aim at therapeutic strategies to control these allergen-independent pathways.
Collapse
Affiliation(s)
- M. Wimmer
- Institute of Environmental Medicine; UNIKA-T; Technische Universität München; Munich Germany
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
| | - F. Alessandrini
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
| | - S. Gilles
- Institute of Environmental Medicine; UNIKA-T; Technische Universität München; Munich Germany
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
| | - U. Frank
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
- Institute of Biochemical Plant Pathology; Helmholtz Zentrum München; Munich Germany
| | - S. Oeder
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
| | - M. Hauser
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
- Christian Doppler Laboratory for Allergy Diagnosis and Therapy; Department of Molecular Biology; University of Salzburg; Salzburg Austria
| | - J. Ring
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
- Department of Dermatology and Allergy Biederstein; TU Munich; Munich Germany
| | - F. Ferreira
- Christian Doppler Laboratory for Allergy Diagnosis and Therapy; Department of Molecular Biology; University of Salzburg; Salzburg Austria
| | - D. Ernst
- Institute of Biochemical Plant Pathology; Helmholtz Zentrum München; Munich Germany
| | - J. B. Winkler
- Research Unit Environmental Simulation at the Institute of Biochemical Plant Pathology; Helmholtz Zentrum München; Munich Germany
| | - P. Schmitt-Kopplin
- Research Unit Analytical BioGeoChemistry; Helmholtz Zentrum München; Munich Germany
- Analytical Food Chemistry; Technische Universität München; Munich Germany
| | - C. Ohnmacht
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
| | - H. Behrendt
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
| | - C. Schmidt-Weber
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
| | - C. Traidl-Hoffmann
- Institute of Environmental Medicine; UNIKA-T; Technische Universität München; Munich Germany
- Christine Kühne - Center for Allergy Research and Education; Zurich Switzerland
- Department of Dermatology and Allergy Biederstein; TU Munich; Munich Germany
| | - J. Gutermuth
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Zentrum München; Member of the German Center for Lung research (DZL); Munich Germany
- Department of Dermatology and Allergy Biederstein; TU Munich; Munich Germany
- Department of Dermatology; Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel; Brussel Belgium
| |
Collapse
|
7
|
Cicala C, Ialenti A. Adenosine signaling in airways: toward a promising antiasthmatic approach. Eur J Pharmacol 2013; 714:522-5. [PMID: 23850943 DOI: 10.1016/j.ejphar.2013.06.033] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2013] [Revised: 06/14/2013] [Accepted: 06/21/2013] [Indexed: 12/16/2022]
Abstract
Adenosine participates to asthma physiopathology by signaling through more than just one receptor subtype. Defining the role of each receptor is complicated by evidence that often results obtained on rodents do not coincide with human studies, but what emerges is that an important condition to establish hyperresponsiveness to adenosine in any species of sensitized animals is the exposure to allergen; this feature appears to be very similar to the human situation, since allergic humans regularly undergo exposure to allergen. Furthermore, A₂B in humans, but A₃ receptor in rodents, would mediate, indirectly, the bronchoconstriction in response to adenosine and would play the main role in adenosine-induced airway inflammation and airway hyperreactivity. On the other hand, A₁ receptor over-expressed on asthmatic airways would mediate a direct adenosine bronchoconstrictor effect. Antagonists and agonists to adenosine receptors have been considered as antiasthmatic drugs but often their development has been limited by unwanted effects. Preventing adenosine accumulation in airways should be considered as a novel promising antiasthmatic strategy.
Collapse
Affiliation(s)
- Carla Cicala
- Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131, Naples, Italy.
| | | |
Collapse
|